School of Medicine Coronavirus Update:
Read for more details specific to medical students and School of Medicine events.

Master of Science (M.S) Clinical and Translational Science

Clinical and Translational Science Overview 

Translational science is the application of the results from the basic research on cells and animals to the treatment of patients. With rapid developments in technology and genomics, this translational science is changing the advancement of medical care so that prevention and treatment of disease is specific to each individual patient. Much of this personalized medicine is dependent on clinical and translational sciences (CTS). 

Marshall University Joan C. Edwards School of Medicine (JCESOM) equips CTS M.S. students with the information and training necessary to translate basic advances into improved patient care that will enhance the quality of life for patients in the Appalachian region, particularly southern West Virginia. Marshall’s CTS M.S. program has expanded to meet both the needs of our students and the demands of our economy. Graduates of Marshall’s CTS M.S. program will be able to lead all aspects of clinical trials of new drugs and procedures. This program provides an emphasis on conducting clinical trials and research specific to the rural regions of West Virginia.

Marshall is now providing three areas of emphasis within the program: Clinical Trials, Clinical Research (Health-Related Professional School Preparation), and Clinical Informatics.


Contact Us

Submit form below with any questions you have about the program.

Minimum Admission Requirements 

  • Baccalaureate degree from an accredited college or university. 
  • Minimum 3.0 GPA overall with a 3.0 for combined science and math courses is recommended.
    • Under certain circumstances, the minimum GPA requirement may be waived on a case-by-case basis. 
  • Completion of all prerequisite coursework with a grade "C" or better.
  • No entrance exam required. 

Prerequisite Coursework 

  • Two semesters of general biology and associated laboratories.
  • Two semesters of general chemistry and associated laboratories.
  • Two semesters of organic chemistry and associated laboratories.
  • Two semesters of physics and associated laboratories.
  • One semester of biochemistry or cell biology are highly recommended but not required. 

Application Process 

  • Submit the Clinical and Translational Science M.S. application and supporting documents on BioMedCas Applicant Portal
    • When creating BioMedCas account, select 2020-2021 cycle  
  • Supporting Documents required: 
    • Official Transcripts 
    • Written Statement 
      • Your statement should address your educational and career goals, and why you should be admitted to the Clinical and Translational Science M.S. program. 
    • Three Letters of Recommendation 
      • Letters of recommendation from STEM-related Professors preferred.  
      • Recommendation requests can be found under "Supporting Information" of BioMedCas application. 
    • Resume or CV
    • International Students ONLY, will need to submit proof of English Proficiency and affidavit of financial support. 
      • TOEFL minimum score of 80. 
      • MELAB minimum score of 82. 
      • IELTS minimum score of 6.5.
  • Pay $80 application fee on BioMedCas Applicant Portal. 
  • Deadline to apply for International Students is March 15th. 

Apply NOW!

Depending on funding, a limited number of scholarships may be available for CTS MS students. Each scholarship is in the amount of a full year (fall, spring and summer terms) of in-state tuition and fees for the program. Metro, Non-WV residents and international students are eligible for the scholarship; however, the amount provided will remain the same.

This is not a tuition remission or a full scholarship, so students may want to contact the Assistant Director of Student Financial Assistance, Cindy Canterberry, MS, at 304-691-8739 or via email at madden2@marshall.edu.

For additional financial aid information, visit Marshall University's Financial Aid website or contact the financial aid office to speak with a representative. 

Old Main, Room 116
304-696-3162
sfa@marshall.edu

All students are required to meet the general requirements of the Graduate College for receipt of a master's degree. A minimum of 36 credit hours is required for a non-thesis degree. In addition, all students must pass a written and/or oral comprehensive exam. All students will take the following courses within their area of emphasis. 

Students will learn all aspects of administering a clinical trial including study design, research operations, regulatory requirements, recruiting techniques, rural health disparities and more.

CTS Core Courses  
Course Number Course Name Credit Hours
CTS 600 Epidemiology and Biostatistics Used in Medical Research 3
CTS 614 Online Survey Tools, Relational and Data Warehousing and Data Manipulation 3
CTS 620 Basic Clinical Research Operations 3
CTS 640* Clinical Trials Journal Club* (x4) 1
CTS 660 Molecular Phenotype of Appalachian Disorders 3
BMR 680* Seminar* (x4) 1
Area of Emphasis in Clinical Trials Courses
CTS 610 Study Design and Applied Statistics in Medical Research 3
CTS 625 Clinical Research Operations Lab 5
CTS 630 Fundamentals of Team Science   2
CTS 635 Writing and Peer Review of Scientific Publications 1
CTS 650 Rural Clinic Experience 5
BMR 660 Communication Skills I 1
BMR 661 Communication Skills II 1
Total Credit Hours 43
Taken More Than Once *

While being trained in clinical trials, participants will develop a strengthened science foundation for application to health-related professional schools.

CTS Core Courses  
Course Number Course Name Credit Hours
CTS 600 Epidemiology and Biostatistics Used in Medical Research 3
CTS 614 Online Survey Tools, Relational and Data Warehousing and Data Manipulation 3
CTS 620 Basic Clinical Research Operations 3
CTS 640* Clinical Trials Journal Club* (x2) 1
CTS 660 Molecular Phenotype of Appalachian Disorders 3
BMR 680* Seminar* (x4) 1
Area of Emphasis in Clinical Research (Health Profession) Courses
CTS 610 OR BMR 617 Study Design and Applied Statistics in Medical Research OR Research Techniques for the Biomedical Sciences 3
CTS 625 Clinical Research Operations Lab 5
BMR 601 Introduction to Nucleic Acids and Proteins 3
BMR 602 Introduction to Cell Structure and Metabolism 3
BMR 603 Regulation of Cell Function 2
BMR 604 Cellular Basis of Disease 1
BMR 882 Research 4
PHY 667 OR PMC 621 Pharmacology I OR Experimental Approaches to Physiology 1
Total Credit Hours 45
Taken More Than Once *

Applicants will study the elements of clinical trials while focusing on data manipulation, machine learning, and clinical programming.

CTS Core Courses  
Course Number Course Name Credit Hours
CTS 600 Epidemiology and Biostatistics Used in Medical Research 3
CTS 614 Online Survey Tools, Relational and Data Warehousing and Data Manipulation 3
CTS 620 Basic Clinical Research Operations 3
CTS 640* Clinical Trials Journal Club* (x1) 1
CTS 660 Molecular Phenotype of Appalachian Disorders 3
BMR 680* Seminar* (x2) 1
Area of Emphasis in Clinical Informatics Courses
CTS 610 Study Design and Applied Statistics in Medical Research 3
CTS 611* Machine Learning Journal Club* (x1) 1
CTS 612 Introduction to Clinical Machine Learning 3
CTS 615 Introduction to Clinical Database 3
CTS 616 Introduction to Clinical Programming Using C# 3
CTS 628 Introduction to Java Clinical Programming 4
CTS 630 Fundamentals of Team Science 2
CTS 635 Writing and Peer Review of Scientific Publications 1
CTS 637 Introduction to Tableau 3
CTS 645 Navigating Health IT 3
CTS 650 Rural Clinic Experience 5
BMR 660 Communication Skills I 1
BMR 661 Communications Skills II 1
Total Credit Hours 45
Taken More Than Once *

For more information regarding Active Clinical Trials, contact our Medical Director of Clinical Trials - Usha Murughiyan (304) 691-1836.

Active Clinical Trials  
Study ID  PI  Currently Enrolling  Description  Contact Information 
NCT03971071
Ferguson  Yes A Study to Evaluate the Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache  Nicole Finley
NCT01809002
Koester  No Comparison of Processed Nerve Allograft and Collagen Nerve Cuffs for Peripheral Nerve Repair (AxoGen AVIVE) Sandra Finley (Ortho)
NCT01442194 Ferguson  No Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies  (PASSAGE)  Linda Morgan 
NCT03257358 Ferguson  N/a A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod (FLUENT) - Closed to Enrollment Linda Morgan 
NCT03277313 Shephard No Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric PIDD Subjects   Nicole Finley 
NCT03537508 Shields Yes Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine when Administered Concomitantly with Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US (MET 42 SANOFI)  Mallori Scarberry, Mallori Scarberry; Sara Runyon 
NCT03012776 Phan  Yes A Pivotal Study of the Premia Spine TOPS System (TOPS IDE) Linda Morgan 
NCT02907177 Ferguson  No Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated with Dimethyl Fumarate (Tecfidera)(POINT) - Closed to Enrollment  Linda Morgan 
NCT04032093 Keblawi No A Phase 2B Placebo-Controlled, Randomized Study of a Respiratory Syncytial Virus (RSV) Vaccine in Pregnant Women   Mallori Scarberry
NCT01809002 Koester  Yes  Comparison of Processed Nerve Allograft and Collagen Nerve Cuffs for Peripheral Nerve Repair (RECON) Sandra Finley (Ortho)
NCT03028740 Sundaram Yes AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults with NASH Nicole Finely 
NCT03781791 Shivkumar Yes Orally Administered ENT-01 for the Treatment of Parkinson's Disease-Related Constipation (KARMET)
Sara Runyon
NCT03984305 Shivkumar  Yes Utilization of Target Ranges to Treat Patients with Parkinson's Disease by Objective Measurement Using the Personal KinetiGraph (PKG) compared to Standard of Care Assessment (TARGET-PD)- A Randomized Controlled Trial Study 003 Sara Runyon 

Updated on August 5, 2020. 

For more information on PI Initiated Clinical Trials, contact our Medical Director of Clinical Trials - Usha Murughiyan (304) 691-1836

PI Initiated Clinical Trials  
IRB Number  PI  Description 
827507 Egleton, Richard  NAS 
921118 Cyphert, Holly HERD 2020/2021
GRANT  Sundaram, Uma  NIH COBRE
GRANT  Sundaram, Uma NIH Ro1
GRANT  Sundaram,  Uma  Ro1NET
499630 Koester, Alan AVANTA (SRTMMCP)
463451 Koester, Alan AVANTA (SRTMPIP)

Updated on April 3, 2020.  

Clinical Trials 

  • Clinical Trial Coordinator 
  • Clinical Project Manager 
  • Clinical Recruitment Coordinator 

Clinical Research - Health Professions 

  • Medical School 
  • Pharmacy School 
  • Physician Assistant (PA) School

Clinical Informatics 

  • Data Scientist 
  • Data Warehouse Research Analyst
  • Insurance Outcomes Predictor 

Applicants will be considered until June 30, if openings are available. 

Leadership 

Uma Sundaram, MD

Vice DeanOffice of Research & Graduate Education
Phone: (304) 691-1841
sundaramu@marshall.edu

Richard Egleton, PhD

Co-DirectorMU JCESOM Graduate Program 
Phone: (304) 696-3523
egleton@marshall.edu


Marlenea Brand, MPA

Administrative Director of Graduate Studies
Phone: (304) 696-7399
brandm@marshall.edu